StockData
Organigram Global Inc. logo

Organigram Global Inc. (OGI) stock

OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 16, 2025Score 4/30
$0.68−0.03 (-4.29%)

Close on Nov 18, 2026Market cap $90.98MP/E –Yield –

Organigram Global operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -C$15.30M. The highest annual figure on record is C$36.42M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-C$15.30M–
FY2022Aug 31, 2022-C$43.15M–
FY2021Aug 31, 2021-C$91.82M–
FY2020Aug 31, 2020-C$145.51M-2751.9%
FY2019Aug 31, 2019C$5.49M-84.9%
FY2018Aug 31, 2018C$36.42M–

More Organigram Global figures

See a number that looks wrong?